{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:54:46Z","timestamp":1783648486088,"version":"3.55.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The newest method of treatment for patients with NSCLC (non-small cell lung cancer) is immunotherapy directed at the immune checkpoints PD-1 (Programmed Cell Death 1) and PD-L1 (Programmed Cell Death Ligand 1). PD-L1 is the only validated predictor factor for immunotherapy efficacy, but it is imperfect. Some patients do not benefit from immunotherapy and may develop primary or secondary resistance. This study aimed to assess the intestinal resistome composition of non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors in the context of clinical features and potentially new prediction factors for assessing immunotherapy efficacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study included 30 advanced NSCLC patients, 19 (57%) men and 11 (33%) women treated with first- or second-line immunotherapy (nivolumab, pembrolizumab or atezolizumab). We evaluated the patient\u2019s gut resistome composition using the high sensitivity of targeted metagenomics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Studies have shown that resistome richness is associated with clinical and demographic factors of NSCLC patients treated with immunotherapy. Smoking seems to be associated with an increased abundance of macrolides, lincosamides, streptogramins and vancomycin core resistome. The resistome of patients with progression disease appears to be more abundant and diverse, with significantly higher levels of genomic markers of resistance to lincosamides (<jats:italic>lnuC<\/jats:italic>). The resistance genes <jats:italic>lnuC<\/jats:italic>, <jats:italic>msrD<\/jats:italic>, <jats:italic>ermG<\/jats:italic>, <jats:italic>ap<\/jats:italic>h(6), <jats:italic>fosA<\/jats:italic> were correlated with progression-free survival or\/and overall survival, thus may be considered as factors potentially impacting the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results indicate that the intestinal resistome of NSCLC patients with immune checkpoint inhibitors treatment differs depending on the response to immunotherapy, with several distinguished markers. Since it might impact treatment efficacy, it must be examined more deeply.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2024.1378900","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:40:53Z","timestamp":1723005653000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Gut resistome of NSCLC patients treated with immunotherapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Ewelina","family":"Iwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Bomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Bieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Wasyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kieszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rolska-Kopi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Chmielewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Rybczy\u0144ska-Tkaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Olejnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Milanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1128\/AAC.49.7.2716-2719.2005","article-title":"New lnu (C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36","volume":"49","author":"Achard","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"D690","DOI":"10.1093\/nar\/gkac920","article-title":"CARD 2023: expanded curation, support for machine learning, and resistome prediction at the comprehensive antibiotic resistance database","volume":"51","author":"Alcock","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ijantimicag.2011.07.010","article-title":"Investigation of the prevalence of tetQ, tetX and tetX1 genes in bacteroides strains with elevated tigecycline minimum inhibitory concentrations","volume":"38","author":"Bartha","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B4","doi-asserted-by":"publisher","first-page":"ofab187","DOI":"10.1093\/ofid\/ofab187","article-title":"Incidence of infections and predictors of mortality during checkpoint inhibitor immunotherapy in patients with advanced lung cancer: a retrospective cohort study","volume":"8","author":"Bavaro","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"D744","DOI":"10.1093\/nar\/gkac1047","article-title":"MEGARes and AMR++, v3.0: an updated comprehensive database of antimicrobial resistance determinants and an improved software pipeline for classification using high-throughput sequencing","volume":"51","author":"Bonin","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B6","first-page":"1266416","article-title":"Decolonization of asymptomatic carriage of multi-drug resistant bacteria by bacteriophages?","volume-title":"Frontiers in microbiology","author":"Bonnet","year":"2023"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.3390\/cancers12123729","article-title":"Primary and acquired resistance to immunotherapy in lung cancer: unveiling the mechanisms underlying of immune checkpoint blockade therapy","volume":"12","author":"Boyero","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"dlad026","DOI":"10.1093\/jacamr\/dlad026","article-title":"Characterization of vancomycin-resistance vanD gene clusters in the human intestinal microbiota by metagenomics and culture-enriched metagenomics","volume":"5","author":"Brochu","year":"2023","journal-title":"JAC-Antimicrobial Resist"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/B978-0-323-04579-7.00135-0","article-title":"Macrolides, ketolides, lincosamides and streptogramins","author":"Bryskier","year":"2010","journal-title":"Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/imt2.107","article-title":"Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp","volume":"2","author":"Chen","year":"2023","journal-title":"iMeta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/IAI.00527-20","article-title":"Cigarette smoke exposure promotes virulence of Pseudomonas aeruginosa and induces resistance to neutrophil killing","volume":"88","author":"Chien","year":"2020","journal-title":"Infect. Immun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1075593","DOI":"10.3389\/fonc.2023.1075593","article-title":"A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors","volume":"13","author":"Crespin","year":"2023","journal-title":"Front. Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/jac\/dkn388","article-title":"Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains","volume":"62","author":"Domelier","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B16","volume-title":"Antimicrobial resistance surveillance in Europe - 2020","year":"2022"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e07209","DOI":"10.2903\/j.efsa.2022.7209","article-title":"The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2019\u20132020","volume":"20","year":"2022","journal-title":"EFSA J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/annonc\/mdz206","article-title":"The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?","volume":"30","author":"Elkrief","year":"2019","journal-title":"Ann. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1469-0691.2006.01569.x","article-title":"Emergence of VanD-type vancomycin-resistant Enterococcus faecium in Stockholm, Sweden","volume":"13","author":"Fang","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"B20","first-page":"2","volume-title":"Cigarette smoking promotes the spread of antimicrobial resistance in the human lung and the environment","author":"Fang","year":"2023"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1080\/10408398.2015.1077192","article-title":"Antimicrobial resistance: a global emerging threat to public health systems","volume":"57","author":"Ferri","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1188872","DOI":"10.3389\/fmicb.2023.1188872","article-title":"Targeted metagenomics using bait-capture to detect antibiotic resistance genes in retail meat and seafood","volume":"14","author":"Flint","year":"2023","journal-title":"Front. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s40168-023-01610-1","article-title":"Resistome expansion in disease-associated human gut microbiomes","volume":"11","author":"Fredriksen","year":"2023","journal-title":"Microbiome"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/nejmoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/gutjnl-2018-317220","article-title":"Microbiota and cancer immunotherapy: in search of microbial signals","volume":"68","author":"Gharaibeh","year":"2019","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1093\/jac\/dkt255","article-title":"Lincosamide resistance mediated by lnu(C) (L phenotype) in a Streptococcus anginosus clinical isolate","volume":"68","author":"Gravey","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.3390\/cancers14246250","article-title":"Attempting to identify bacterial allies in immunotherapy of NSCLC patients","volume":"14","author":"Grenda","year":"2022","journal-title":"Cancers"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1126\/science.abc9113","article-title":"Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy","volume":"373","author":"Griffin","year":"2021","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"153928","DOI":"10.1016\/j.scitotenv.2022.153928","article-title":"Different fosA genes were found on mobile genetic elements in Escherichia coli from wastewaters of hospitals and municipals in Turkey","volume":"824","author":"G\u00fcneri","year":"2022","journal-title":"Sci. Total Environ."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s41467-019-08853-3","article-title":"Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage","volume":"10","author":"Hendriksen","year":"2019","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12885-023-10623-w","article-title":"Clinical impact of tetracyclines and\/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort study","volume":"23","author":"Hsieh","year":"2023","journal-title":"BMC Cancer"},{"key":"B33","first-page":"1362","article-title":"Antimicrobial resistance and its drivers\u2014a review","volume-title":"Antibiotics (basel)","author":"Irfan","year":"2022"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e00749","DOI":"10.1128\/mBio.00749-17","article-title":"Widespread fosfomycin resistance in gram-negative bacteria attributable to the chromosomal fosA gene","volume":"8","author":"Ito","year":"2017","journal-title":"MBio"},{"key":"B35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12967-022-03409-4","article-title":"Transcriptomic datasets of cancer patients treated with immune-checkpoint inhibitors: a systematic review","volume":"20","author":"Kov\u00e1cs","year":"2022","journal-title":"J. Transl. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40168-017-0387-y","article-title":"In-depth resistome analysis by targeted metagenomics","volume":"6","author":"Lanza","year":"2018","journal-title":"Microbiome"},{"key":"B37","first-page":"19","article-title":"Lung microbiome: new insights into the pathogenesis of respiratory diseases","volume-title":"Signal transduction and targeted therapy","author":"Li","year":"2024"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e160811","DOI":"10.2903\/J.EFSA.2018.E160811","article-title":"Risk assessment of antimicrobial resistance along the food chain through culture-independent methodologies","volume":"16","author":"Likotrafiti","year":"2018","journal-title":"EFSA J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"809761","DOI":"10.3389\/fimmu.2022.809761","article-title":"A new trend in cancer treatment: the combination of epigenetics and immunotherapy","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jtho.2020.03.002","article-title":"NSCLC immunotherapy efficacy and antibiotic use: a systematic review and meta-analysis","volume":"15","author":"Lurienne","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.18332\/tid\/113528","article-title":"Cigarette smoke exposure induces expression of the pneumococcal erm(B) macrolide resistance gene","volume":"17","author":"Matapa","year":"2019","journal-title":"Tob. Induc. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1128\/AAC.45.11.3246-3249.2001","article-title":"Novel tetracycline resistance gene, tet(32), in the Clostridium-related human colonic anaerobe K10 and its transmission in vitro to the rumen anaerobe Butyrivibrio fibrisolvens","volume":"45","author":"Melville","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jgar.2022.05.014","article-title":"Characterization of the resistome in Lactobacillus genomic sequences from the human gut","volume":"30","author":"Moradi","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12940-020-00620-y","article-title":"Bisphenol A shapes children\u2019s brain and behavior: towards an integrated neurotoxicity assessment including human data","volume":"19","author":"Mustieles","year":"2020","journal-title":"Environ. Heal. A Glob. Access Sci. Source"},{"key":"B45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/14756366.2017.1344235","article-title":"Beta-lactamase database (BLDB)\u2013structure and function","volume":"32","author":"Naas","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3322\/caac.21697","article-title":"Antibiotic resistance in the patient with cancer: escalating challenges and paths forward","volume":"71","author":"Nanayakkara","year":"2021","journal-title":"Ca. Cancer J. Clin."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.3390\/cancers13194824","article-title":"The gut microbiome and cancer immunotherapy: can we use the gut microbiome as a predictive biomarker for clinical response in cancer immunotherapy?","volume":"13","author":"Oh","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.12938\/bmfh.17-004","article-title":"Detection of antibiotic resistance genes in the feces of young adult Japanese","volume":"36","author":"Ohashi","year":"2017","journal-title":"Biosci. Microbiota, Food Heal."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/jac\/dkq346","article-title":"Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli","volume":"65","author":"Oteo","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.21037\/atm.2019.05.72","article-title":"Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 \u226550%, but unanswered questions remain","volume":"7","author":"Pacheco","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/antibiotics12071161","article-title":"Prevalence of enterococci and vancomycin resistance in the throat of non-hospitalized individuals randomly selected in Central Italy","volume":"12","author":"Palmieri","year":"2023","journal-title":"Antibiotics"},{"key":"B73","article-title":"Macrolides","author":"Patel","year":"2023","journal-title":"StatPearls [Internet]"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/jcm9051458","article-title":"Survival of patients treated with antibiotics and immunotherapy for cancer: a systematic review and meta-analysis","volume":"9","author":"Petrelli","year":"2020","journal-title":"J. Clin. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1128\/CMR.00019-15","article-title":"A structure-based classification of class A \u03b2-lactamases, a broadly diverse family of enzymes","volume":"29","author":"Philippon","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.20517\/mrr.2023.23","article-title":"Bifidobacterium in anticancer immunochemotherapy: friend or foe?","volume":"2","author":"Procaccianti","year":"2023","journal-title":"Microbiome Res. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fmicb.2011.00040","article-title":"Environmental macrolide-lincosamide-streptogramin and tetracycline resistant bacteria","volume":"2","author":"Roberts","year":"2011","journal-title":"Front. Microbiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsle\/fnad097","article-title":"Analysis of BlaEC family class C beta-lactamase","volume":"370","author":"Schmidt","year":"2023","journal-title":"FEMS Microbiol. Lett."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/B978-0-323-04579-7.00131-3","article-title":"Mechanisms of antibacterial resistance","author":"Schmitz","year":"2010","journal-title":"Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2016.00098","article-title":"Macrolide resistance in Streptococcus pneumoniae","volume":"6","author":"Schroeder","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/br.2021.1490","article-title":"Mechanisms of gram-positive vancomycin resistance (review)","volume":"16","author":"Selim","year":"2022","journal-title":"Biomed. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40793-023-00482-0","article-title":"Exploiting a targeted resistome sequencing approach in assessing antimicrobial resistance in retail foods","volume":"18","author":"Shay","year":"2023","journal-title":"Environ. Microbiome"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41598-022-05817-4","article-title":"Impact of long-term dietary habits on the human gut resistome in the Dutch population","volume":"12","author":"Stege","year":"2022","journal-title":"Sci. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41467-023-36781-w","article-title":"Development of the oral resistome during the first decade of life","volume":"14","author":"Sukumar","year":"2023","journal-title":"Nat. Commun."},{"key":"B63","first-page":"1091165","article-title":"The human microbiome: a promising target for lung cancer treatment","volume-title":"Frontiers in immunology","author":"Sun","year":"2023"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaoncol.2019.2187","article-title":"Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab","volume":"5","author":"Topalian","year":"2019","journal-title":"JAMA Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.anaerobe.2010.08.008","article-title":"Genetic analysis of mobile tetQ elements in oral Prevotella species","volume":"16","author":"Tribble","year":"2010","journal-title":"Anaerobe"},{"key":"B66","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.idc.2020.08.002","article-title":"Multidrug-resistant bacteria in the community: an update","volume":"34","author":"van Duin","year":"2020","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B67","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/annonc\/mdy041","article-title":"Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases","volume":"29","author":"Vokes","year":"2018","journal-title":"Ann. Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"10906","DOI":"10.3390\/ijms231810906","article-title":"Cancer resistance to immunotherapy: molecular mechanisms and tackling strategies","volume":"23","author":"Vu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1128\/AAC.00788-08","article-title":"Characterization of tet(32) genes from the oral metagenome","volume":"53","author":"Warburton","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S1470-2045(19)30167-6","article-title":"Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"West","year":"2019","journal-title":"Lancet Oncol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"892401","DOI":"10.3389\/fcimb.2022.892401","article-title":"Analysis of gut microbiota signature and microbe-disease progression associations in locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy","volume":"12","author":"Xi","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jiac.2020.07.013","article-title":"Cigarette smoke extract induces the Pseudomonas aeruginosa nfxC drug-resistant phenotype","volume":"26","author":"Xu","year":"2020","journal-title":"J. Infect. Chemother."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1378900\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:40:59Z","timestamp":1723005659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1378900\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":73,"alternative-id":["10.3389\/fgene.2024.1378900"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1378900","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"article-number":"1378900"}}